Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

被引：9
|
作者：
Langabeer, Stephen E. [1 ]
McCarron, Sarah L.
Carroll, Peig
Kelly, Johanna [2 ]
O'Dwyer, Michael [3 ]
Conneally, Eibhlin [4 ]
机构：
[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland
[2] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland
[3] Natl Univ Ireland, Dept Haematol, Galway, Ireland
[4] St James Hosp, Dept Haematol, Dublin 8, Ireland
来源：
LEUKEMIA RESEARCH | 2011年 / 35卷 / 09期
关键词：
IMATINIB; MUTATION; DISEASE;
D O I：
10.1016/j.leukres.2011.05.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E169 / E170
页数：2
相关论文
共 50 条
  • [21] Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
    Smith, Brittany M.
    Brewer, Diana
    Druker, Brian J.
    Braun, Theodore P.
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1707 - 1711
  • [22] Assessment of BCR-ABL1 Fusion Transcripts and Their Association with Response to Imatinib Treatment in Chronic Myeloid Leukemia Patients
    Kagita, Sailaja
    Mamidi, Tulasi Krishna
    Digumarti, Leela
    Gundeti, Sadasivudu
    Digumarti, Raghunadharao
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2018, 39 (02) : 165 - 171
  • [23] BCR-ABL1 transcript decline ratio combined BCR-ABL1IS as a precise predictor for imatinib response and outcome in the patients with chronic myeloid leukemia
    Cai, Zhimei
    Jia, Xiting
    Zi, Jie
    Song, Huihui
    Wang, Shujun
    McGrath, Mary
    Zhao, Lidong
    Song, Chunhua
    Ge, Zheng
    JOURNAL OF CANCER, 2020, 11 (08): : 2234 - 2240
  • [24] Oxidative Stress and BCR-ABL1 Transcript Levels in Chronic Myeloid Leukemia: an Intricate Relationship
    Pascu, Emilia Georgiana
    Gaman, Mihnea Alexandru
    Moisa, Cornel
    Gaman, Amelia Maria
    REVISTA DE CHIMIE, 2019, 70 (09): : 3193 - 3196
  • [25] Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type
    Baccarani, Michele
    Rosti, Gianantonio
    Soverini, Simona
    LEUKEMIA, 2019, 33 (10) : 2358 - 2364
  • [26] International Reporting Scale of BCR-ABL1 Fusion Transcript in Chronic Myeloid Leukemia: First Report from India
    Balasubramanian, Poonkuzhali
    Chendamarai, Ezhilarasi
    Markose, Preetha
    Fletcher, Linda
    Branford, Susan
    George, Biju
    Mathews, Vikram
    Chandy, Mammen
    Srivastava, Alok
    ACTA HAEMATOLOGICA, 2012, 127 (03) : 135 - 142
  • [27] Genotyping of Chimerical BCR-ABL1 RNA in Chronic Myeloid Leukemia by Integrated DNA Chip
    Kang, Jong-Hun
    Goh, Hyun-Gyung
    Chae, Sang-Ho
    Kim, Sung-Yong
    Kim, Dong-Wook
    Chae, Chi-Bom
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (05) : 487 - 493
  • [28] Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line
    Stephanie Dulucq
    Gabriel Etienne
    Stephane Morisset
    Emilie Klein
    Claudine Chollet
    Fanny Robbesyn
    Beatrice Turcq
    Isabelle Tigaud
    Sandrine Hayette
    Franck E. Nicolini
    François-Xavier Mahon
    Annals of Hematology, 2019, 98 : 1159 - 1168
  • [29] Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
    Ha, Jihye
    Cheong, June-Won
    Shin, Saeam
    Lee, Seung-Tae
    Choi, Jong Rak
    ANNALS OF LABORATORY MEDICINE, 2016, 36 (03) : 287 - 289
  • [30] Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
    Haddad, Fadi
    Kantarjian, Hagop
    Issa, Ghayas C.
    Jabbour, Elias
    Sasaki, Koji
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1714 - 1717
12345